Paratek Pharmaceuticals Inc

Carlyle Group Inc.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/4/2023

Shares

1,041,131

Value ($000)

2,301

Weight

0.1%

2023 Q1 - 2023 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/4/2023	2,301	0.1%	1,041,131	6/30/2023
2023 Q1	5/5/2023	2,624	0.1%	1,041,131	3/31/2023